Fortress Biotech Inc (FBIO)
1.94
+0.18
(+10.23%)
USD |
NASDAQ |
May 17, 16:00
1.94
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Shareholders Equity (Quarterly): 23.02M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 23.02M |
December 31, 2023 | 22.54M |
September 30, 2023 | 16.67M |
June 30, 2023 | 18.51M |
March 31, 2023 | 37.80M |
December 31, 2022 | 41.72M |
September 30, 2022 | 61.67M |
June 30, 2022 | 77.22M |
March 31, 2022 | 97.86M |
December 31, 2021 | 108.67M |
September 30, 2021 | 92.66M |
June 30, 2021 | 108.28M |
March 31, 2021 | 105.90M |
December 31, 2020 | 100.34M |
September 30, 2020 | 97.11M |
June 30, 2020 | 60.48M |
March 31, 2020 | 37.23M |
December 31, 2019 | 26.22M |
September 30, 2019 | 25.80M |
June 30, 2019 | 31.87M |
March 31, 2019 | 20.82M |
December 31, 2018 | 1.852M |
September 30, 2018 | 37.77M |
June 30, 2018 | 43.93M |
March 31, 2018 | 41.65M |
Date | Value |
---|---|
December 31, 2017 | 52.57M |
September 30, 2017 | 36.94M |
June 30, 2017 | 72.27M |
March 31, 2017 | 47.75M |
December 31, 2016 | 38.50M |
September 30, 2016 | 36.63M |
June 30, 2016 | 35.34M |
March 31, 2016 | 44.56M |
December 31, 2015 | 56.85M |
September 30, 2015 | 53.61M |
June 30, 2015 | 55.88M |
March 31, 2015 | 60.15M |
December 31, 2014 | 70.52M |
September 30, 2014 | 69.26M |
June 30, 2014 | 72.37M |
March 31, 2014 | 75.49M |
December 31, 2013 | 81.28M |
September 30, 2013 | 87.51M |
June 30, 2013 | 48.56M |
March 31, 2013 | 26.73M |
December 31, 2012 | 22.03M |
September 30, 2012 | 29.13M |
June 30, 2012 | 33.82M |
March 31, 2012 | 13.45M |
December 31, 2011 | 19.13M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
16.67M
Minimum
Sep 2023
108.67M
Maximum
Dec 2021
59.58M
Average
51.10M
Median
Shareholders Equity (Quarterly) Benchmarks
Journey Medical Corp | 12.95M |
Avenue Therapeutics Inc | 2.836M |
Checkpoint Therapeutics Inc | -10.25M |
Mustang Bio Inc | 0.123M |
Viking Therapeutics Inc | 933.89M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 164.64M |
Total Liabilities (Quarterly) | 168.58M |
Debt to Equity Ratio | 2.798 |
Current Ratio | 1.329 |
Net Debt Paydown Yield | 20.23% |